These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16445652)

  • 1. Detection of chromosomal aberrations by fluorescence in situ hybridization in cervicovaginal biopsies from women exposed to diethylstilbestrol in utero.
    Hajek RA; King DW; Hernández-Valero MA; Kaufman RH; Liang JC; Chilton JA; Edwards CL; Wharton JT; Jones LA
    Int J Gynecol Cancer; 2006; 16(1):318-24. PubMed ID: 16445652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
    Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
    Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
    J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DES exposure: an update.
    Mittendorf R; Herbst AL
    Contemp Pediatr; 1994 Nov; 11(11):59-62, 64, 66 passim. PubMed ID: 10150281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diethylstilbestrol-exposed monozygotic twins discordant for cervicovaginal clear cell adenocarcinoma.
    Sandberg EC; Christian JC
    Am J Obstet Gynecol; 1980 May; 137(2):220-8. PubMed ID: 7189642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Huo D; Anderson D; Palmer JR; Herbst AL
    Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
    White MC; Weir HK; Soman AV; Peipins LA; Thompson TD
    Cancer Causes Control; 2022 Aug; 33(8):1121-1124. PubMed ID: 35767133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis.
    Kurita T; Mills AA; Cunha GR
    Development; 2004 Apr; 131(7):1639-49. PubMed ID: 14998922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of cervicovaginal abnormalities in DES-exposed women. A comparison of changes in sexually inactive women and the effects of the onset of sexual activity.
    Frank AR; Krumholz BA; Deutsch S
    J Reprod Med; 1985 May; 30(5):400-3. PubMed ID: 4009562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol.
    Robboy SJ; Keh PC; Nickerson RJ; Helmanis EK; Prat J; Szyfelbein WM; Taft PD; Barnes AB; Scully RE; Welch WR
    Obstet Gynecol; 1978 May; 51(5):528-35. PubMed ID: 652199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
    Laronda MM; Unno K; Butler LM; Kurita T
    Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States.
    Smith EK; White MC; Weir HK; Peipins LA; Thompson TD
    Cancer Causes Control; 2012 Jan; 23(1):207-11. PubMed ID: 22015647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological studies of the effects of diethylstilboestrol.
    Vessey MP
    IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.